Sort   by:  
 Page size 
UnknownCCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.
Not available
S-EPMC4437873 | biostudies-literature
UnknownHepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.
Not available
S-EPMC5207118 | biostudies-literature
UnknownSymptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
Not available
S-EPMC10918565 | biostudies-literature
UnknownTumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types.
Not available
S-EPMC11815411 | biostudies-literature
GenomicsLBC_Methylation - samples
DNA methylation data using Illumina 450K
EGAD00010000604 | EGA
GenomicsDNA methylation repeatability in the Lothian Birth Cohorts of 1921 and 1936.
The repeatability of longitudinal measures of whole blood DNA methylation (obtained using the Illumina 450k chip) was assessed in two cohorts of ageing. The Lothian Birth Cohort of 1921 and the Lothian Birth Cohort of 1936. Data were collected at ages 70, 73, and 76 (LBC1936) and 79, 87, 90 (LBC1921...
EGAS00001000910 | EGA
GenomicsLongitudinal DNA methylation in the Lothian Birth Cohorts of 1921 and 1936
Data Access Committee EGAC00001000218
EGAC00001000218 | EGA
GenomicsEGAD00000000055
COLO-829 is a publicly available immortal cancer cell line and COLO-829BL is a lymphoblastoid cell line derived from the same patient
EGAD00000000055 | EGA
GenomicsA Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome
We have carried out complete sequencing of the genome of the human male maligant melanoma cell line COLO-829 using the Illumina Genome Analyzer II. We generated a sequencing library with a median insert size of ~200 bp following random fragmentation and gel fractionation of the genomic DNA. We seque...
EGAS00000000052 | EGA
UnknownAbiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Not available
S-EPMC9321995 | biostudies-literature
Sort   by:  
 Page size